Hutchin Hill Capital’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-19,300
Closed -$715K 610
2017
Q3
$715K Buy
19,300
+600
+3% +$22.5K 0.03% 422
2017
Q2
$693K Buy
18,700
+200
+1% +$6.53K 0.02% 601
2017
Q1
$520K Sell
18,500
-6,400
-26% -$181K 0.01% 641
2016
Q4
$730K Buy
+24,900
New +$680K 0.03% 520
2015
Q4
Sell
-32,900
Closed -$1.04M 717
2015
Q3
$1.04M Buy
32,900
+5,100
+18% +$186K 0.04% 408
2015
Q2
$1.08M Buy
+27,800
New +$959K 0.03% 442

Other funds holding PAHC

Hutchin Hill Capital's PAHC Position: Q4 2017 in Review

Hutchin Hill Capital sold out of Phibro Animal Health (PAHC) in Q4 2017, closing a stake of 19,300 shares — an estimated $715K sold.

Hutchin Hill Capital first reported a position in PAHC in Q2 2015 and held it in 6 quarters. The position peaked at $1.08M in Q2 2015. 169 funds tracked by Wall St. Rank hold PAHC as of Q4 2017.

  • Hutchin Hill Capital reported no remaining Phibro Animal Health position as of Q4 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 19,300 Phibro Animal Health shares in Q4 2017, an estimated $715K.
  • Hutchin Hill Capital first reported a position in Phibro Animal Health in Q2 2015 and held it in 6 quarters.
  • Hutchin Hill Capital's Phibro Animal Health position peaked at $1.08M in Q2 2015.
  • 169 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.